Bingchamides a and b, two novel cyclic pentapeptides from the Streptomyces bingchenggensis: Fermentation, isolation, structure elucidation and biological properties

Journal of Antibiotics

Volumn 62, Issue 9, 2009, Pages 501-505

  Xiang, Wen Sheng ^a   Wang, Ji Dong ^b   Wang, Xiang Jing ^a   Zhang, Ji ^a  

^a NORTHEAST AGRICULTURAL UNIVERSITY   (China)

^b Zhejiang Hisun Pharmaceutical   (China)

Author keywords

Antitumor activity; Bingchamides a and b; Cyclic pentapeptides; Streptomyces bingchenggensis

Indexed keywords

ANTINEOPLASTIC AGENT; BINGCHAMIDE A; BINGCHAMIDE B; PENTAPEPTIDE; SANSALVAMIDE A; UNCLASSIFIED DRUG;

ARTICLE; BACTERIUM ISOLATION; CARBON NUCLEAR MAGNETIC RESONANCE; CELL STRAIN HCT116; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; DRUG STRUCTURE; ELECTROSPRAY MASS SPECTROMETRY; FERMENTATION TECHNIQUE; HUMAN; HUMAN CELL; IN VITRO STUDY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; STEREOCHEMISTRY; STREPTOMYCES; STREPTOMYCES BINGCHENGGENSIS; ULTRAVIOLET SPECTROSCOPY;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; FERMENTATION; HUMANS; MOLECULAR SEQUENCE DATA; MYCELIUM; PEPTIDES, CYCLIC; STREPTOMYCES;

STREPTOMYCES;

EID: 70349594562     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.1038/ja.2009.60     Document Type: Article

References (21)

1. Xiang, W. S., Wang, J. D., Wang, X. J. & Zhang, J. Two new-class milbemycins from Streptomyces bingchenggensis Fermentation, isolation, structure elucidation and biological properties. J. Antibiot. 60, 351-356 (2007).
2. Xiang, W. S., Wang, J. D., Wang, X. J., Zhang, J. & Wang, Z. Further new milbemycin antibiotics from Streptomyces bingchenggensis. J. Antibiot. 60, 608-613 (2007).
3. Xiang, W. S., Wang, J. D., Fan, H. M., Wang, X. J. & Zhang, J. New Seco-milbemycins from Streptomyces bingchenggensis: fermentation, isolation and structure elucidation. J. Antibiot. 60, 27-32 (2008).
4. Xiang, W. S., Wang, J. D., Wang, X. J. & Zhang, J. A novel macrolide compound from Streptomyces bingchenggensis fermentation, isolation, structure elucidation and biological properties. J. Antibiot. 62, 229-231 (2009).
5. Hwang, Y. et al. Mechanism of inhibition of a poxvirus topoisomerase by the marine natural product sansalvamide. A. Mol. Pharmacol. 6, 1049-1053 (1999).
6. Lee, Y. & Silverman, R. B. Rapid, high-yield, solid-phase synthesis of the antitumor antibiotic sansalvamide A using a side-chain-tethered phenylalanine building block. Org. Lett. 2, 3743-3746 (2000).
7. Gu, W., Liu, S. & Silverman, R. B. Solid-phase, Pd-catalyzed siliconaryl carbon bond formation. Synthesis of sansalvamide A peptide. Org. Lett. 4, 4171-4174 (2002).
8. Carroll, C. L. et al. Synthesis and cytotoxicity of novel sansalvamide A derivatives. Org. Lett. 7, 3481-3484 (2005).
9. Otrubova, K. et al. Synthesis and novel structure-activity relationships of potent sansalvamide A derivatives. Chem. Commun. 9, 1033-1034 (2006).
10. Otrubova, K., McGuire, K. L. & McAlpine, S. R. Scaffold targeting drug-resistant colon cancers. J. Med. Chem. 9, 1999-2002 (2007).
11. Tan, N. H. & Zhou, J. Plant Cyclopeptides. Chem. Rev. 106, 840-895 (2006).
12. Liu, Y. Q. et al. Design and synthesis of cyclo[-Arg-Gly-Asp-c(triazole)- Gly-Xaa-] peptide analogues by click chemistry. Tetrahedron 47, 10728-10734 (2008).
13. Harvey, A. L. Natural products in drug discovery. Drug Discov. Today 13, 895-901 (2008).
14. Otrubova, K., Lushington, G., McGuire, K. L. & McAlpine, S. R. Comprehensive study of sansalvamide A derivatives and their structure-activity relationships against drug-resistant colon cancer cell lines. J. Med. Chem. 3, 530-544 (2008).
15. Davis, M. R. et al. Synthesis and cytotoxicity of a new class of potent decapeptide macrocycles. Org. Lett. 2, 177-180 (2008).
16. Pan, P. S., McGuire, K. L. & McAlpine, S. R. Identification of Sansalvamide A analog potent against pancreatic cancer cell lines. Bioorg. Med. Chem. Lett. 18, 5072-5077 (2007).
17. Rodriguez, R. A. et al. Synthesis of second-generation sansalvamide A derivatives: novel templates as potential antitumor agents. J. Org. Chem. 6, 1980-2002 (2007).
18. Styers, T. J. et al. Synthesis of Sansalvamide A derivatives and their cytotoxicity in the MSS colon cancer cell line HT-2. Bioorg. Med. Chem. 16, 5625-5631 (2006).
19. Otrubova, K. et al. Synthesis and novel structure-activity relationships of potent sansalvamide A derivatives. Chem. Commun. 9, 1033-1034 (2006).
20. Ujiki, M. B. et al. A novel peptide sansalvamide analogue inhibits pancreatic cancer cell growth through G0/G1 cell-cycle arrest. Biochem. Biophys. Res. Commun. 4, 1224-1228 (2006).
21. Wijnhoven, B. P. et al. Human oesophageal adenocarcinoma cell lines JROECL 47 and JROECL 50 are admixtures of the human colon carcinoma cell line HCT 11. Br. J. Cancer. 9, 1510-1512 (2000).